Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.

@article{Brenner2005LongtermSR,
  title={Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.},
  author={Hermann Brenner and Volker Arndt},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2005},
  volume={23 3},
  pages={441-7}
}
PURPOSE In the era of widespread prostate specific antigen (PSA) screening, a large proportion of older men have to live with a diagnosis of prostate cancer. In this study, we applied a new method for up-to-date analysis of long-term survival to evaluate if and to what extent these patients still have any excess mortality compared to the general population. METHODS Five- and 10-year absolute and relative survival rates for the year 2000 were derived from the 1973 to 2000 database of the… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
31 Citations
32 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 31 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 32 references

ERSPC: Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial

  • HJ de Koning, MK Liem, CA Baan
  • Int J Cancer 98:268-273,
  • 2002

Similar Papers

Loading similar papers…